The Food and Drug Administration has approved Reyvow, a new pill made by Eli Lilly that treats migraine attacks. The drugmaker did not immediately disclose the drug's price.
The big picture: Reyvow is not approved for the prevention of migraines, but other new drugs on the market — Aimovig, Ajovy and Emgality — are described as preventative for migraines.
Juul says new retail software successfully curbed underage purchases and wants all stores that sell its products to eventually use it, Bloomberg reports.
The catch: Retailers gripe about changing their check-out software for 1 product. The system locks up if there are bulk purchases or if an invalid ID is scanned.
The delay in implementing comprehensive regulations for e-cigarettes has contributed to a growing crisis of vaping-related illnesses and deaths across the U.S. and poses particular risks to young adults.
The big picture: E-cigarette use by American teenagers has surged, and the dangers are heightened by unsafe black market vaping devices and THC cartridges. But a recent flurry of regulatory activity by states looks set to continue, with federal action following shortly.
President Trump may be telling voters everything that they want to hear when it comes to health care, but much of it isn't true.
Why it matters: Trump is claiming victories he hasn't achieved and making promises he's not prepared to live up to, all on an immensely personal subject that voters consistently rank as one of the most important issues of 2020.
Purdue Pharma has to resolve ongoing inquiries with the Justice Department before finalizing its plan to enter bankruptcy, the Wall Street Journal reports, citing the newly released terms of the settlement.
Why it matters: Purdue's bankruptcy plan, and its proposed settlement to resolve the national opioids lawsuit, are already facing resistance from state and local governments.
As world leaders, advocates and others meet in France this week to discuss the Global Fund's replenishment for its programs targeting tuberculosis, HIV and malaria, a group of international experts say malaria can be completely eradicated within this generation — via more funding, new data tools, political will and promising drugs.
Why it matters: The fight against malaria has seen great overall progress since 2000, with death rates dropping 60%, global incidences falling 36% and more than half of all countries reporting being free of malaria. However, it still kills a child every 2 minutes and the fight has plateaued or lost ground in some parts of the world.
Almost three-quarters of likely 2020 voters support banning flavored vaping products, according to a new survey by Schoen Consulting, commissioned by the Campaign for Tobacco-Free Kids.
Why it matters: Some Republicans have warned that President Trump's proposed ban on flavors could anger vapers and risk his 2020 chances, as Axios' Alayna Treene has reported, but this survey suggests there's more political risk to inaction.
The Trump administration is proposing to loosen regulations that prohibit doctors from steering patients insured by federal programs to facilities where they have a financial interest and that outlaw health care companies from offering bribes and kickbacks in exchange for patient referrals.
Why it matters: The industry has long clamored for an overhaul to these laws, which companies say obstruct their goals of providing "value-based care." But critics worry the broad and vague changes could engender more fraud and abuse than there already is.
